Kuczyńska-Zardzewiały A, Rodo M, Członkowska A
Kliniki Chorób Naczyniowych Układu Nerwowego Instytutu Psychiatrii i Neurologii w Warszawie.
Neurol Neurochir Pol. 1988 May-Jun;22(3):211-5.
In 27 patients with reliably diagnosed Wilson's disease treated previously with penicillamine (Cuprenil, Polfa) for from 10 months to 12 years penicillamine was withdrawn due to various adverse effects and replaced with zinc sulphate (Polish preparation Zincteral) in doses of 200 mg 4 times daily for 12 months. The neurological status was improved in 6 cases. No adverse effects of zinc sulphate were observed.
在27例已确诊为威尔逊氏病的患者中,他们此前使用青霉胺(商品名Cuprenil、Polfa)治疗了10个月至12年,因出现各种不良反应而停用青霉胺,换用硫酸锌(波兰制剂Zincteral),剂量为每日4次,每次200毫克,持续治疗12个月。6例患者的神经状态有所改善。未观察到硫酸锌的不良反应。